ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1397	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	cancer treatment 0.423589 PDQ cancer information 0.483377 lymph flow 0.481362 leg 0.408261 left lymph duct 0.48735 white blood cells 0.398624 secondary lymphedema 0.507085 clinical trials 0.422847 cancer information summary 0.440651 clinical trial 0.38593 tiny lymph vessels 0.509598 breast cancer patients 0.459436 sentinel lymph node 0.518746 certified lymphedema therapists 0.498842 breast cancer survivors 0.394173 upper-body exercise 0.39564 NCI PDQ cancer 0.395621 Untreated lymphedema 0.491735 lymph nodes 0.686068 swollen area 0.380684 radiation therapy 0.378654 treatment 0.447311 Lymphedema section 0.47523 lymphedema sleeves 0.47753 severe lymphedema 0.470942	skin 0.4219 Cancer Information Service 0.379239 Primary lymphedema 0.49612 lymph 0.792134 body tissues 0.403337 larger lymph vessels 0.508148 Stage III lymphedema 0.489621 National Cancer Institute 0.439823 arm 0.413813 lymphedema therapist 0.534874 Palliative Care Editorial 0.381473 lymph vessels 0.714976 limb 0.427251 lymphedema 0.932301 certified lymphedema therapist 0.527418 breast cancer 0.483638 Care Editorial Board 0.382648 pressure garment 0.387805 lymphedema increases 0.491902 swollen limb 0.388807 lymph fluid 0.457795 cancer information summaries 0.378678 comprehensive cancer information 0.377712 cancer 0.547119	CLICK HERE
1589	National Cancer Institute	Html	en	Adrenocortical Carcinoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adrenocortical carcinoma.	treatment 0.550891 malignant tumor cells 0.393623 cancer treatment 0.339234 NCI-supported cancer 0.325244 cancer cells 0.380323 Adrenocortical Carcinoma Home 0.328751 adrenal cortex 0.482225 body 0.41124 adrenocortical carcinoma spreads 0.336583 PDQ cancer information 0.400868 adrenal medulla 0.329784 clinical trial search 0.399161 treatment clinical trials 0.346018 affected adrenal gland 0.313913 National Cancer Institute 0.418105 clinical trials 0.816364 adrenal gland 0.62258 High blood pressure 0.300595 Adrenal gland cells 0.329473 normal cells 0.306099 cancer information summary 0.36038 clinical trial 0.576848 Adrenocortical Carcinoma Treatment 0.355819	new treatment 0.426441 nonfunctioning adrenocortical tumor 0.334163 detailed pictures 0.31402 patients 0.305698 adrenocortical carcinoma 0.949806 Recurrent adrenocortical carcinoma 0.379499 adrenocortical carcinoma cells 0.349105 adrenal glands 0.394752 blood 0.322073 nuclear magnetic resonance 0.302225 PDQ summary 0.318647 treatment clinical trial 0.305174 NCI PDQ cancer 0.312561 Treatment Option Overview 0.314325 cancer clinical trials 0.41336 lymph nodes 0.306574 radiation therapy 0.311431 Treatment Editorial Board 0.302427 cancer 0.760261 information 0.413368 standard treatment 0.301619 adrenocortical carcinoma depend 0.345997 positron emission tomography 0.305618	CLICK HERE
1669	National Cancer Institute	Html	en	Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood craniopharyngioma	evidence 0.541909 subtotal resection 0.652496 intensity-modulated photon therapy 0.593647 Aylwin et al. 0.579904 Merchant TE 0.567828 radiation therapy section 0.596714 PDQ cancer information 0.54907 Conventional radiation therapy 0.591705 Tumors Treatment Overview 0.55265 radiation dose 0.548781 Int J Radiat 0.614894 photon radiation therapy 0.573627 craniopharyngiomas 0.555197 cancer information summary 0.541422 Radiat Oncol Biol 0.7952 irradiated craniopharyngioma 0.570882 standard fractionated radiation 0.630603 Tan et al. 0.575816 conformal radiation treatments 0.560832 proton therapy 0.60593 tumor control 0.588032 common solid tumor 0.565687 recurrent cystic tumor 0.550194 radiation therapy 0.986329 Morisako et al. 0.5808	spare normal tissue 0.555535 Neurosurg Focus 0.546254 et al. 0.839112 complete resection 0.561879 magnetic resonance imaging 0.576707 newer radiation technologies 0.623865 gross-total resection 0.656285 brain tumor treatment 0.599377 residual craniopharyngioma 0.590756 pediatric craniopharyngioma 0.701375 stereotactic radiation therapy 0.599058 PUBMED Abstract 0.577489 craniopharyngioma cyst growth 0.621968 childhood craniopharyngioma 0.72734 Abstract 0.609429 external-beam radiation therapy 0.569508 pediatric brain tumors 0.558017 Sterkenburg et al. 0.578437 Oncol Biol Phys 0.807866 Neurosurg Pediatr 0.63126 recurrent craniopharyngioma 0.572364 papillary craniopharyngioma 0.570471 tumor 0.617686 craniopharyngioma 0.809351	CLICK HERE
1730	National Cancer Institute	Html	en	Blood-Forming Stem Cell Transplants	A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.	red blood cells 0.400014 cancer treatment 0.26536 cord blood 0.408194 public cord blood 0.298389 bone marrow cells 0.392639 cord blood bank 0.313292 embryonic stem cells 0.414015 cord stem cells 0.382315 healthy cells 0.309763 bone marrow donation 0.293131 white blood cells 0.53145 transplanted stem cells 0.39836 HLA-matched stem cells 0.374986 clinical trials 0.346744 healthy stem cells 0.372316 stem cells 0.95315 stem cell transplant 0.291072 multiple myeloma 0.26697 Bone marrow aspiration 0.292859 cord blood banks 0.343333 immature cells 0.319355 HLA antigens 0.259199 appropriate unrelated donor 0.262231 radiation therapy 0.329306 transplantation 0.292216	blood-forming stem cells 0.415789 immature nerve cells 0.328089 Large volunteer donor 0.262362 new blood cells 0.334223 blood stem cell 0.339528 cancer cells 0.404042 special blood test 0.260646 peripheral blood stem 0.362146 anticancer drugs 0.263549 donor 0.356002 PBSCT 0.299118 patient 0.341681 marrow’s ability 0.258871 blood stem cells 0.413585 healthy bone marrow 0.302284 umbilical cord blood 0.366965 umbilical cord 0.389737 harvested cells 0.30119 commercial cord blood 0.270418 Marrow Donor Program® 0.288844 BMT 0.322432 bone marrow 0.850438 autologous transplant 0.272369 hematopoietic stem cells 0.478378	CLICK HERE
1734	National Cancer Institute	Html	en	Diethylstilbestrol (DES) and Cancer	A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb.	DES grandsons 0.538814 Hatch EE 0.382563 DES exposure 0.67711 Cell Cancer Registry 0.421337 pregnant women 0.436903 mothers 0.380607 Pap test 0.370345 researchers 0.371735 pregnancy 0.387046 slightly increased risk 0.395077 DES Follow-up Study 0.632841 DES-exposed women 0.392223 health problems 0.418784 slightly higher risk 0.374572 prenatal DES exposure 0.579068 hormone replacement therapy 0.402773 possible health effects 0.424124 health effects 0.485372 women 0.613207 DES daughters 0.874038 abnormal cells 0.390363 overall cancer risk 0.3987 prenatally exposed men 0.392794 regular breast cancer 0.374945	Hormonal Transplacental Carcinogenesis 0.419307 third-generation daughters 0.375828 DES-exposed daughters 0.446699 adverse health effects 0.420665 clear cell adenocarcinoma 0.541335 unexposed women 0.492521 DES granddaughters 0.631672 studies 0.380945 National Cancer Institute 0.372742 Military medical records 0.370524 higher risk 0.376562 breast cancer risk 0.433356 breast cancer 0.508269 birth defects 0.404912 cervical intraepithelial neoplasia 0.371506 DES-exposed mothers 0.370151 DES 0.962997 squamous intraepithelial lesions 0.371888 abnormal cell changes 0.370094 Clear Cell Cancer 0.418711 et al 0.459666 New England Journal 0.400964 cancer 0.517317 risk 0.491261	CLICK HERE
1981	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para pacientes	Sumario informativo revisado por expertos sobre el tratamiento y la atención del paciente de cáncer desde los últimos días hasta las últimas horas de vida; esto incluye los síntomas comunes, los dilemas éticos que pueden surgir y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este período.	etapa final 0.952722 alientoLa sensación 0.303004 siguientes afecciones 0.302215 Mejor comunicación 0.301527 posibles daños 0.30146 Contracciones mioclónicasLas 0.30427 siguientes tipos 0.302214 PDQ Aflicción 0.302895 PDQ Etapa final 0.30437 suficiente oxígeno 0.302526 HemorragiaLa hemorragia 0.303897 vía rectal 0.302425 obstructiva crónica 0.302498 posibles riesgos 0.304519 efectos directos 0.302483 vías respiratorias 0.375323 muerteEl estertor 0.304331 National Cancer Institute 0.30139 especial cánceres 0.30221 Mejor alivio 0.301759 próximas horas 0.302343	Instituto Nacional 0.302514 PDQ Planificar 0.312661 contracciones súbitas 0.303377 pequeñas cantidades 0.302149 importantes beneficios 0.301883 cuánta probabilidad 0.301726 Physician Data Query 0.305159 LíquidosLos pacientes 0.308282 PDQ Fatiga 0.306846 FatigaLa fatiga 0.303104 PDQ Delirium 0.307935 término instrucciones 0.301507 posibles beneficios 0.301551 nutrición parenteral 0.304251 reanimación cardiorrespiratoria 0.301653 causa sufrimiento 0.302836 Mejor perspectiva 0.301742 sufrimiento extremo 0.306751 numerosos cambios 0.308661 ReanimaciónLos pacientes 0.308108	CLICK HERE
15907	National Cancer Institute	Html	es	Laetrilo (amigdalina) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del laetrilo (amigdalina) como tratamiento para personas con cáncer.	siguientes teorías 0.410914 suficiente información 0.405414 Centro Nacional 0.412476 Phaseolus lunatus 0.410368 New Hampshire Avenue 0.408624 Drug Administration 0.405353 NCI Best Case 0.416678 fase i 0.407749 datos bibliográficos pubmed 0.409348 largo plazo 0.408034 siguientes preguntas 0.406283 vitamina b17 0.411219 cuáles tipos 0.408099 vitamina c 0.408062 vitamina a 0.409071 siguientes riesgos 0.407854 seguro médico 0.405074 Instituto Nacional 0.512438	Salud Complementaria 0.418716 Visuals Online 0.406445 siguientes resultados 0.443523 complementarias revisa 0.408971 Physician Data Query 0.437362 siguientes causas 0.409284 Estados Unidos 0.980672 enzimas pancreáticas 0.42962 Corte Suprema 0.408891 libre uso 0.407165 determinadas frutas 0.407416 página manejo 0.406016 ¿El tratamiento 0.415719 ¿Los beneficios 0.405473 juntos cam 0.405199 Series Program 0.405225 medicina complementaria 0.651404	CLICK HERE
16184	National Cancer Institute	Html	es	Manejo de costos y de información médica	Las personas con cáncer y sus familias pueden enfrentarse a mayores retos económicos. El tratamiento de cáncer puede ser muy caro, aun cuando se tenga seguro. Aprenda cómo mantener la cuenta de tratamientos y de pruebas, de formularios y cobros, y más.	cuáles tratamientos 0.380156 Busque programas 0.344502 información médica clave.  0.356222 médico muestras 0.355273 expediente personal 0.405493 Health Information Management 0.361343 importante cuál sistema 0.365142	mayores retos 0.375386 Busque asistencia 0.353171 Busque formas 0.327721 Sociedad Americana 0.349375 busque ayuda 0.333405 seguro médico 0.91222 mano.  revise cuáles 0.413273	CLICK HERE
16717	National Cancer Institute	Html	en	Cancer Clinical Trials at the National Institutes of Health Clinical Center	Information about cancer clinical trials at the NIH Clinical Center in Bethesda, Maryland.	cancer treatment 0.534356 better understanding 0.369317 clinical program 0.414778 eligibility criteria 0.37194 health insurance 0.371915 novel cancer treatment 0.457878 International patients 0.371646 health care provider 0.502194 clinical trial experience 0.462664 clinical teams 0.407146 NIH physicians 0.420773 Patients page 0.377331 NCI clinic 0.401655 open trials 0.377021 in-house cancer center 0.477433 Patient Self-Referral Form 0.427003 unique hospital 0.366285 clinical trials 0.623234 treatment services 0.380122 health care providers 0.57596 approach fosters interaction 0.418119 National Institutes 0.375152 clinical trial 0.527278 contact information 0.370247 CCR clinical trials 0.482065	patients 0.409802 cancer patients 0.399962 standard treatment options 0.440025 trial’s eligibility 0.38116 related research 0.378808 patient care units 0.440886 United States 0.412623 largest hospital 0.37768 cancer research 0.528759 NIH Clinical Center 0.949828 National Cancer Institute 0.460111 NCI research team 0.453825 Clinical Research Referral 0.467688 Developmental Therapeutics Clinic 0.698646 advanced cancer 0.386466 trial information 0.38805 new treatments 0.372193 NCI principal investigator 0.437174 patient treatment plans 0.430619 compassionate doctors 0.368527 care specialists 0.389607 medical care 0.431584 scientific resources 0.368533 trial summary 0.38584	CLICK HERE
17189	National Cancer Institute	Html	en	Sexual Health Issues in Women with Cancer	Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.	cancer treatment 0.51645 vaginal tissue 0.532819 primary ovarian insufficiency 0.548774 endocrine therapy 0.478386 health care team 0.776749 sexual life 0.612375 support group 0.540233 gynecologic cancers 0.477639 social worker 0.530013 pelvic muscles 0.474973 sexual activity 0.559668 sexual health 0.668647 sexual intercourse 0.555683 low estrogen levels 0.65848 hair loss 0.473268 physical changes 0.478751 birth control 0.564552 Fertility Issues 0.55759 effects 0.479305 sexual problems 0.5327 hot flashes 0.548172 radiation therapy 0.542011 long term 0.480571 valuable suggestions 0.473342 vaginal dryness 0.649951	vaginal gels 0.527917 problems 0.541005 women 0.505517 cancer treatments 0.472282 treatment 0.973526 sex life 0.471664 personal health factors 0.547006 vaginal secretions 0.525892 cancer-related support services 0.536181 changes 0.511207 Vaginal stenosis 0.532538 vaginal wall 0.531486 vaginal atrophy 0.531565 hormone therapy 0.536753 sexual changes 0.501579 bladder retention 0.472634 shorter vagina 0.48061 sexual health expert 0.553722 support groups 0.47572 Breast Cancer 0.475837 doctor 0.494029 bowel function 0.475187 national organizations 0.470856 time 0.509374	CLICK HERE